TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/11CD160A.svg?ark=w1%2F20260526%2F11CD160A&value=id)](https://nobleid.org/work/w1/20260526/11CD160A)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors